Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways

Journal of Cell Biology

Volumn 151, Issue 6, 2000, Pages 1131-1140

  Lawlor, Margaret A ^a   Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Akt; Insulin like growth factors; MyoD; p21; Phosphatidyl inositol 3 kinase

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MYOD PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P21; SOMATOMEDIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; ENZYME ACTIVITY; MOUSE; MUSCLE CELL; MUSCLE HYPERTROPHY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, ANTISENSE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOD PROTEIN; SIGNAL TRANSDUCTION; STEM CELLS;

ANIMALIA;

EID: 0034638844     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.151.6.1131     Document Type: Article

References (71)

1. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis
2. Muscle differentiation: More complexity to the network of myogenic regulators
3. p21: Structure and functions associated with cyclin-CDK binding
4. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
5. The role of the IGF-I receptor in apoptosis
6. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases
7. Rhoa GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts
8. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1
9. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
10. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
11. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis
12. Cellular survival: A play in three Akts
13. Mice lacking p21/CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
14. p21/p53, cellular growth control and genomic integrity
15. Cell cycle checkpoints: Preventing an identity crisis
16. 'Spontaneous' differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II
17. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
18. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells
19. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
20. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
21. The expanding role of cell cycle regulators
22. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B
23. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation
24. Insulin-like growth factors and their binding proteins: Biological actions
25. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression blocks differentiation of L6E9 muscle cells
26. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway
27. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells
28. Induction of NF-kappaB by the Akt/PKB kinase
29. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal
30. Dual control of muscle cell survival by distinct growth factor regulated signaling pathways
31. Insulin-like growth factor-mediated muscle cell survival: Central roles for Akt and the cyclin-dependent kinase inhibitor, p21
32. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
33. Pattern of the insulin-like growth factor II gene expressin during early mouse embryogenesis
34. Molecular and cellular aspects of the insulin-like growth factor I receptor
35. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade
36. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
37. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells
38. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage
39. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I
40. Regulation and function of the Rho subfamily of small GTPases
41. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out
42. Inactivation of MyoD-mediated expression of p21 in tumor cell lines
43. p53-Independent expression of p21/Cip1 in muscle and other terminally differentiating cells
44. The cyclin-dependent kinase inhibitor p21/WAF1 is required for survival of differentiating neuroblastoma cells
45. IGF-I is required for normal embryonic growth in mice
46. Phosphorylation and activation of p70s6k by PDK1
47. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis
48. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
49. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
50. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts
51. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation
52. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit
53. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation
54. Growth, differentiation and survival: Multiple physiological functions for insulin-like growth factors
55. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts
56. The Rho family of G proteins play a critical role in muscle differentiation
57. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation
58. Insulin like growth factors (IGF) in muscle development
59. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation
60. Protein-protein interactions in insulin signaling and the molecular mechanisms of insulin resistance
61. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation
62. RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation
63. The retinoblastoma protein and cell cycle control
64. The MyoD family and myogenesis: Redundancy, networks and thresholds
65. p38 and Extracellular signal-regulated kinase regulate the myogenic program at multiple steps
66. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
67. Targeting the p38 mitogen-activated protein kinases to MEF2 transcription factors
68. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis
69. p38 Mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor
70. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step
71. Regulation of the MEF2 family of transcription factors by p38